Skill for curating microbiome-related pathophysiology in the dismech knowledge base. Use this skill when adding dysbiosis mechanisms, ecological concepts (Anna Karenina, keystone taxa, colonization resistance), SCFA/metabolite pathways, and linking microbial ecology to disease pathophysiology. Covers IBD, C. diff, obesity, and other microbiome-associated conditions.
Scanned 9/9/2026
Install to Claude Code
npx -y skills add monarch-initiative/dismech --skill microbiome-curation --agent claude-codeInstalls into .claude/skills of the current project.
Are you the author of Microbiome Curation?
Add the live security badge to your README — it updates automatically with every re-scan.
[](https://www.skillsdirectory.com/skills/monarch-initiative-microbiome-curation)More formats (shields.io, HTML) on the badges page.
---
name: microbiome-curation
description: >
Skill for curating microbiome-related pathophysiology in the dismech knowledge base.
Use this skill when adding dysbiosis mechanisms, ecological concepts (Anna Karenina,
keystone taxa, colonization resistance), SCFA/metabolite pathways, and linking
microbial ecology to disease pathophysiology. Covers IBD, C. diff, obesity, and
other microbiome-associated conditions.
---
# Microbiome Curation Skill
## Overview
Curate microbiome-related pathophysiology entries with ecological depth beyond simple
taxa +/- lists. Focus on:
- Ecological concepts (diversity, stability, keystone taxa)
- Causal chains from dysbiosis to clinical manifestations
- Metabolic consequences (SCFA, bile acids)
- Integration with BugSigDB and primary literature
## When to Use
- Adding microbiome dysbiosis entries to disorders
- Curating pathophysiology for IBD, C. diff, obesity, metabolic diseases
- Decomposing "microbiome dysbiosis" into causal graph nodes
- Adding ecological concepts (Anna Karenina, colonization resistance)
- Linking microbial metabolites to host pathophysiology
## Key Principle: Graph Structure Over Monolithic Entries
**DO NOT** create single entries bundling all microbiome effects:
```yaml
# BAD - monolithic entry
- name: Microbiome Dysbiosis
description: >
Reduced diversity with depletion of Firmicutes and expansion of pathobionts,
leading to decreased SCFA and barrier dysfunction.
```
**DO** decompose into atomic nodes with `downstream` edges:
```yaml
# GOOD - causal graph
- name: Loss of Microbial Diversity
downstream:
- target: Loss of Keystone SCFA Producers
- target: Increased Microbial Community Instability
- name: Loss of Keystone SCFA Producers
downstream:
- target: Decreased Butyrate Production
- name: Decreased Butyrate Production
downstream:
- target: Impaired Colonocyte Energy Metabolism
- name: Impaired Colonocyte Energy Metabolism
downstream:
- target: Epithelial Barrier Dysfunction
```
This enables:
1. Shared nodes across disorders
2. Explicit feedback loops
3. Targeted therapeutic entry points
4. Evidence on specific causal steps
## Ecological Dimensions of Dysbiosis
### Beyond Taxa +/-
BugSigDB captures increased/decreased taxa, but ecology is richer:
| Dimension | What it captures | Example |
|-----------|------------------|---------|
| **Taxonomic** | Which species +/- | Faecalibacterium, E. coli |
| **α-Diversity** | Richness/evenness | Shannon index |
| **β-Diversity** | Inter-individual variability | Anna Karenina effect |
| **Functional** | Pathway capacity | Butyrate synthesis genes |
| **Metabolic** | Actual output | Fecal SCFA concentrations |
| **Network** | Community structure | Keystone taxa, modularity |
| **Stability** | Resilience | Alternative stable states |
### Anna Karenina Principle
> "All healthy microbiomes are alike; each dysbiotic microbiome is dysbiotic in its own way."
Dysbiosis often manifests as **increased stochasticity** rather than consistent shift to specific taxa.
```yaml
- name: Increased Microbial Community Instability
description: >
Anna Karenina effect - dysbiotic microbiomes show increased inter-individual
variability and temporal instability. The community loses resilience and may
occupy an alternative stable state that resists therapeutic intervention.
notes: >
This increased stochasticity complicates biomarker discovery and explains
heterogeneous treatment responses.
downstream:
- target: Loss of Microbial Diversity
description: Feedback loop - instability promotes further diversity loss
evidence:
- reference: PMID:28836573
supports: SUPPORT
snippet: "The result is an 'Anna Karenina principle' for animal microbiomes, in which dysbiotic individuals vary more in microbial community composition than healthy individuals."
```
### Keystone Taxa
Low-abundance species with high network connectivity:
| Taxon | Role | Loss Consequence |
|-------|------|------------------|
| *Faecalibacterium prausnitzii* | Butyrate producer, anti-inflammatory | ↓ SCFA, ↑ inflammation |
| *Akkermansia muciniphila* | Mucin degrader, cross-feeding hub | Barrier dysfunction |
| *Clostridium scindens* | 7α-dehydroxylation (bai operon) | Loss of colonization resistance |
| *Roseburia* spp. | Butyrate producer | ↓ SCFA |
### Colonization Resistance (C. diff model)
```yaml
- name: Loss of Colonization Resistance
description: >
The healthy microbiome prevents pathogen colonization through nutrient
competition, niche exclusion, and antimicrobial production. Antibiotic
disruption removes these barriers.
notes: >
Key taxa: Lachnospiraceae, Ruminococcaceae, Collinsella. C. scindens
provides bile acid-mediated resistance via bai operon.
downstream:
- target: Pathogen Germination and Expansion
- name: Loss of Secondary Bile Acid Production
description: >
Depletion of 7α-dehydroxylating bacteria (C. scindens, C. hylemonae)
prevents conversion of primary to secondary bile acids. Primary bile
acids promote pathogen germination; secondary bile acids inhibit it.
downstream:
- target: Pathogen Germination and Expansion
```
## SCFA Pathway Template
Common pattern for butyrate-related mechanisms:
```yaml
- name: Loss of Keystone SCFA Producers
description: >
Depletion of butyrate-producing Firmicutes, particularly Faecalibacterium
prausnitzii, Roseburia spp., and Eubacterium rectale. These keystone taxa
support community structure through cross-feeding.
notes: >
F. prausnitzii is anti-inflammatory; its supernatant reduces colitis in
animal models. Primary butyrate producers use the acetyl-CoA pathway.
downstream:
- target: Decreased Butyrate Production
- name: Decreased Butyrate Production
description: >
Reduced fecal SCFA concentrations, particularly butyrate. Butyrate is
the primary energy source for colonocytes (~70% of energy) and exerts
anti-inflammatory effects via HDAC inhibition and GPR109A signaling.
biological_processes:
- preferred_term: Short-chain Fatty Acid Metabolism
term:
id: GO:0046459
label: short-chain fatty acid metabolic process
downstream:
- target: Impaired Colonocyte Energy Metabolism
- name: Impaired Colonocyte Energy Metabolism
description: >
Colonocytes deprived of butyrate shift from beta-oxidation to glycolysis,
causing energy deficit. This impairs tight junction maintenance, mucus
production, and epithelial renewal.
cell_types:
- preferred_term: Colonic Epithelial Cell
term:
id: CL:0011108
label: colon epithelial cell
downstream:
- target: Epithelial Barrier Dysfunction
```
## Pathobiont Expansion Template
```yaml
- name: Pathobiont Expansion
description: >
Bloom of opportunistic pathobionts (adherent-invasive E. coli, Fusobacterium,
Enterobacteriaceae) that exploit niches vacated by depleted commensals.
Promote inflammation through LPS and epithelial invasion.
downstream:
- target: Mucosal Inflammation
description: LPS and pro-inflammatory molecules
- target: Epithelial Barrier Dysfunction
description: Direct epithelial invasion and tight junction disruption
evidence:
- reference: PMID:26185088
supports: SUPPORT
snippet: "This is often characterized by an increased relative abundance of facultative anaerobic bacteria (e.g., Enterobacteriaeceae, Bacilli) and, at the same time, depletion of obligate anaerobic bacteria."
```
## BugSigDB Integration
### When to Reference BugSigDB
- Identifying which taxa are commonly reported +/- in a condition
- Validating that your keystone taxa match published signatures
- Finding PMIDs for evidence
### How to Search BugSigDB
```bash
# Web interface
open "https://bugsigdb.org/w/index.php?search=ulcerative+colitis"
# R/Bioconductor
# library(bugsigdbr)
# sigs <- getSignatures(condition = "ulcerative colitis")
```
### Adding BugSigDB Notes
```yaml
- name: Loss of Colonization Resistance
notes: >
Metagenomics studies consistently show CDI patients have depleted Lachnospiraceae,
Ruminococcaceae, and Collinsella spp. compared to controls. BugSigDB signatures
confirm depletion of these protective taxa.
```
## Key References
### Ecological Concepts
| Concept | PMID | Citation |
|---------|------|----------|
| Anna Karenina principle | 28836573 | Zaneveld et al. 2017, Nat Microbiol |
| Diversity/stability | 22972295 | Lozupone et al. 2012, Nature |
| Alternative stable states | [search for recent] | Microbiome journal |
### IBD Microbiome
| Topic | PMID | Citation |
|-------|------|----------|
| F. prausnitzii | 18936492 | Sokol et al. 2008, PNAS |
| IBD meta-analysis | 25307765 | Walters et al. 2014, FEBS Lett |
| Dysbiosis patterns | 26185088 | Stecher 2015, Microbiol Spectr |
### C. diff / Colonization Resistance
| Topic | PMID | Citation |
|-------|------|----------|
| bai operon | 32179626 | Reed et al. 2020, J Bacteriol |
| C. scindens | 28066726 | Studer et al. 2016, Front Cell Infect Microbiol |
| Toxin mechanism | 15831824 | Voth & Ballard 2005, Clin Microbiol Rev |
## Ontology Terms
### Biological Processes (GO)
```bash
uv run runoak -i sqlite:obo:go search "short-chain fatty acid"
uv run runoak -i sqlite:obo:go search "microbiome"
```
| Process | GO ID |
|---------|-------|
| SCFA metabolic process | GO:0046459 |
| Modification by symbiont | GO:0044003 |
| Inflammatory response | GO:0006954 |
### Cell Types (CL)
| Cell | CL ID |
|------|-------|
| Colon epithelial cell | CL:0011108 |
| Goblet cell | CL:0000160 |
| Neutrophil | CL:0000775 |
### Organisms (NCBITaxon)
```bash
uv run runoak -i sqlite:obo:ncbitaxon search "Faecalibacterium"
```
**Note:** Do NOT use NCBITaxon in `cell_types` - microbial taxa are not cell types.
Include taxa in `description` or `notes` fields instead.
## Validation
```bash
# Full validation
just validate kb/disorders/MyDisorder.yaml
# Check evidence snippets against the reference cache (seconds, offline)
just count-verified-snippets kb/disorders/MyDisorder.yaml
# Before opening the PR: the batched schema+terms+references sweep CI runs
just validate-disorders kb/disorders/MyDisorder.yaml
# Generate HTML to visualize causal graph
uv run python -m dismech.render kb/disorders/MyDisorder.yaml
open pages/disorders/MyDisorder.html
```
## Common Patterns by Disorder Type
### IBD (UC, Crohn's)
1. Loss of Microbial Diversity
2. Loss of Keystone SCFA Producers (F. prausnitzii)
3. Pathobiont Expansion (AIEC, Fusobacterium)
4. Decreased Butyrate → Colonocyte Energy Deficit
5. Barrier Dysfunction
6. Anna Karenina instability (feedback)
### C. diff Infection
1. Antibiotic-Induced Microbial Depletion
2. Loss of Colonization Resistance
3. Loss of Secondary Bile Acid Production
4. C. difficile Germination and Expansion
5. Toxin Production → Epithelial Death + Neutrophil Recruitment
6. Pseudomembranous Colitis
### Obesity / Metabolic Syndrome
1. Firmicutes/Bacteroidetes ratio shift
2. Increased Energy Harvest
3. Altered Bile Acid Metabolism
4. Gut Barrier Permeability
5. Metabolic Endotoxemia (LPS)
6. Low-grade Inflammation
## Integration with Other Skills
- **dismech-terms**: For ontology lookups (GO, CL, UBERON)
- **dismech-references**: For validating PMID snippets
- **cancer-curator**: Some cancers have microbiome components (colorectal)
Is this your skill, or is something wrong with this listing? Request removal or report an issue. Author removals are honored within 72 hours.
No comments yet. Be the first to comment!